This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
T cells are very potent cancer-fighting cells in our immune system, and are often used in cell-based immunotherapies. Dr. Gerlach is helping to decipher their various identities and behaviors. She is searching for markers on the T cells that delineate cells with different functional properties.
Harvard Medical School | All Cancers | 2014 | Ulrich H. von Andrian, M.D.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.
Immunotherapy updates from the world's largest cancer conference, the Annual Meeting of the American Society for Clinical Oncology (ASCO).